Updates are available Correction dated 2025-08-07
Click to view Correction: https://doi.org/10.1186/s13063-025-08955-y
-
Authors
Cleland, Travis
Jain, Nitin B.
Chae, John
Hansen, Kristine M.
Hisel, Terri Z.
Gunzler, Douglas D.
Whitehair, Victoria C.
Kim, Chong H.
Wilson, Richard D. https://orcid.org/0000-0003-0334-2455
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01HD093661)
- License Information
-
More Information
Article History
Received: 17 December 2019
Accepted: 17 February 2020
First Online: 6 March 2020
Change Date: 7 August 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13063-025-08955-y
Ethics approval
: This trial was approved by MetroHealth Medical Centers Institutional Review Board (IRB), which, as a central IRB, all centers involved in this study had access to and utilized (IRB17–00643). This IRB approved the informed consent utilized on all study participants.
: Not applicable.
: RW and CK are consultants to SPR Therapeutics, Inc. RW has received funding from SPR Therapeutics, Inc. JC is a consultant and chief medical advisor to SPR Therapeutics and owns equity in SPR Therapeutics.
